Gsk Dr Reddys Laboratories

Rediff.com » News » Gsk Dr Reddys Laboratories

News for Gsk Dr Reddys Laboratories

Business

Dr Reddy's acquires GSK's US penicillin facility

Dr Reddy's Laboratories on Wednesday said it has acquired GlaxoSmithKline's US penicillin manufacturing facility and the rights to the Augmentin and Amoxil brands in the United States for an......

Dr Reddy's sells US facility to UAE-based Neopharma

The plant and associated facilities focus on manufacturing or packaging Amoxicilin-based products, which include semi-synthetic penicillin Dr Reddy’s Laboratories has sold the antibiotics......

Dr Reddy's Q1 Net up 52.49% at Rs 550 cr

Pharma major Dr Reddy's Laboratories on Wednesday reported 52 per cent jump in net profit at Rs 550.39 crore (Rs 5.5 billion) for the first quarter ended June 30, on the back of North American......

Dr Reddy's expands its US horizon

Already having a deal with GlaxoSmithKline for marketing its products in various emerging markets, Dr Reddy's Laboratories had this week inked an agreement to buy the latter's oral penicillin......

Domestic pharma market grew by 6.8% in 2023

The Indian pharmaceutical market (IPM) grew 6.8 per cent to touch a turnover of ~1.93 trillion in calendar year 2023, despite volumes going down marginally by 0.9 per cent. Photograph: Amit......

Rediff News

Gsk Dr Reddys Laboratories

News for Gsk Dr Reddys Laboratories

Dr Reddy's acquires GSK's US penicillin facility

Dr Reddy's sells US facility to UAE-based Neopharma

Dr Reddy's Q1 Net up 52.49% at Rs 550 cr

Dr Reddy's expands its US horizon

Domestic pharma market grew by 6.8% in 2023

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS